| 31.2349 0 (0%) | 03-26 09:46 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 37.4 | 1-year : | 38.52 |
| Resists | First : | 32.02 | Second : | 32.97 |
| Pivot price | 31.02  |
|||
| Supports | First : | 30.47 | Second : | 25.35 |
| MAs | MA(5) : | 30.85 |
MA(20) : | 31.37 |
| MA(100) : | 31.75 |
MA(250) : | 29.84 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 26.8 |
D(3) : | 18.9 |
| RSI | RSI(14): 46.4 |
|||
| 52-week | High : | 33.43 | Low : | 23.13 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HAPS ] has closed below upper band by 39.0%. Bollinger Bands are 6.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 31.27 - 31.39 | 31.39 - 31.5 |
| Low: | 30.42 - 30.58 | 30.58 - 30.71 |
| Close: | 30.97 - 31.22 | 31.22 - 31.44 |
HAPS invests in small-cap US stocks perceived to possess strong human capital factors across 11 GICS sectors. From the Solactive GBS United States 2000 Index, HAPS targets the top-scoring human capital firms. This is based on the premise that happy and motivated employees can generate better outcomes. Selection begins with a proprietary scoring methodology that quantitatively measures the contribution of a companys corporate culture to its financial performance based on factors such as employee engagement and motivation, trust and transparency, point-of-view diversity, and compensation fairness. Utilized quantifiable metrics include human capital, behavioral, and data sciences. The portfolio is market-cap-weighted, with a 5% cap on each stock. To maintain sector weights of parent universe, adjustments are made by supplementing predetermined small-cap sector ETFs. The index reconstitutes annually. Prior to September 5, 2023, the ETF's name was Harbor Corporate Culture Small Cap ETF.
Tue, 17 Mar 2026
Rhythm Pharmaceuticals Rare Obesity Drug Study Disappoints - Benzinga
Thu, 19 Feb 2026
Harbor Human Capital Factor US Small Cap ETF Q4 2025 Commentary (HAPS) - Seeking Alpha
Fri, 13 Feb 2026
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof - PTC Therapeutics (NASDAQ:PTCT) - Benzinga
Sat, 20 Dec 2025
Harbor Human Capital Factor US Small Cap ETF Q3 2025 Commentary - Seeking Alpha
Tue, 07 Jan 2025
Worst-Performing Stock ETFs of 2024 - Morningstar
Tue, 17 Sep 2024
HAPI: Why This Large-Cap Human Capital Factor ETF Works - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|